Enteris BioPharma, Inc

The Medicines Company develops products that improve acute hospital care and meets the demands of some of the world's most advanced medical practitioners. The company markets Angiomax for injection, an anticoagulant approved for use in patients undergoing coronary angioplasty procedures. The Medicines Company utilizes its range of clinical and commercial skills to develop products acquired from leading life science innovators. In addition to the approved Angiomax product, The Medicines Company is developing clevidipine, a short-acting calcium channel blocker. The Medicines Company is also conducting significant clinical research to study potential additional indications for Angiomax use. In December of 2003, the Company acquired cangrelor, an anticoagulant that prevents platelet clotting factors from activating, which the company believes has potential uses in coronary angioplasty and cardiac surgery. The Medicines Company has offices in Parsippany, N.J., Waltham, Mass., and Abingdon, United Kingdom.

Medimetriks Pharmaceuticals, Inc. is a leading pharmaceutical company based in Fairfield, NJ, specializing in the development and distribution of prescription and personal care products. With a wide range of brands, including Ciclodan, Clindacin, Genadur, and Synalar, Medimetriks is committed to providing effective solutions for various health and medical conditions. Their products are designed to meet the needs of patients, offering relief and improvement in quality of life. As a trusted name in the industry, Medimetriks Pharmaceuticals, Inc. prioritizes the well-being of their customers. Their team of professionals is dedicated to delivering exceptional customer service and ensuring that inquiries and concerns are addressed promptly. With a focus on innovation and quality, Medimetriks continues to make a positive impact in the healthcare field, providing reliable and effective solutions for patients across the United States.Generated from the website

Celgene is a multinational integrated biopharmaceutical company, established in 1986. The company is engaged in the discovery, development and commercialization of therapies designed to treat cancer and immunological diseases through regulation of genomic and proteomic targets. Some of its marketed products include REVLIMID, THALOMID, ALKERAN, FOCALIN, cellular and tissue therapeutics, as well as the RITALIN family of drugs. The company s Signal Pharmaceuticals subsidiary is a privately held San Diego-based biopharmaceuticals company, focused on the discovery and development of drugs that regulate genes associated with diseases. Its other subsidiary, Anthrogenesis Corporation is a privately held New Jersey-based biotherapeutics company and cord blood banking business that is one of the pioneers in the recovery of stem cells from human placental tissue. Celgene is headquartered in Summit, N.J.